Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

University of Toronto

$70,000.00

K-Ras oncogene interaction with Met receptor signaling in colorectal cancer

FY 2008-09

Summary
Colorectal cancer (CRC) is the second leading cause of death from cancer. Oncogenic K-Ras mutations occur in 40-50% of CRC, 70% of which also overexpress Met, the hepatocyte growth factor receptor (HGF). The purpose of my project is to define the Met/K-Ras - regulated signaling pathways that are needed for malignant progression in CRC. We hypothesize that downstream targets of Met and K-Ras are crucial regulators of tumour progression, and represent important prognostic markers and therapeutic targets in the treatment of CRC patients. I will be looking for signaling mediators unique to the Met/K-Ras pathway using an approach based on protein phosphorylation. Protein phosphorylation represents one of the most important mechanisms of conducting and regulating cellular signaling. In these experiments, the DLD-1 CRC cell line (expressing overactive K-Ras), and the DKO-4 daughter cell line (expressing normal K-Ras), along with Met-overexpressing versions of both of these lines will be examined. Phosphorylated peptides from these four cell lines will be identified and quantified using high-resolution mass spectrometry and data analysis software. The information gained from this study will be used to better map the signal transduction pathways downstream of the Met/K-Ras interaction that are important in CRC progression. As well, the biological significance of novel Met phosphorylation sites or interacting proteins will be considered. To complement this project, I am creating a parallel model system of Met/K-Ras interaction in the H460 non-small cell lung cancer (NSCLC) cell line in order to determine if any signaling mediators we find in CRC are also relevant in NSCLC. This project has a significant chance of identifying important prognostic markers, as well as targets for developing novel targeted therapies for CRC.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
184623
Name
Organ Shawna L
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
K-Ras oncogene interaction with Met receptor signaling in colorectal cancer
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$70,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cell Biology; Colorectal Cancer; K-Ras; Met/Hgf; Molecular Biology; Phospho-Proteomics; Signal Transduction; Tyrosine Kinases
Abstract
Colorectal cancer (CRC) is the second leading cause of death from cancer. Oncogenic K-Ras mutations occur in 40-50% of CRC, 70% of which also overexpress Met, the hepatocyte growth factor receptor (HGF). The purpose of my project is to define the Met/K-Ras - regulated signaling pathways that are needed for malignant progression in CRC. We hypothesize that downstream targets of Met and K-Ras are crucial regulators of tumour progression, and represent important prognostic markers and therapeutic targets in the treatment of CRC patients. I will be looking for signaling mediators unique to the Met/K-Ras pathway using an approach based on protein phosphorylation. Protein phosphorylation represents one of the most important mechanisms of conducting and regulating cellular signaling. In these experiments, the DLD-1 CRC cell line (expressing overactive K-Ras), and the DKO-4 daughter cell line (expressing normal K-Ras), along with Met-overexpressing versions of both of these lines will be examined. Phosphorylated peptides from these four cell lines will be identified and quantified using high-resolution mass spectrometry and data analysis software. The information gained from this study will be used to better map the signal transduction pathways downstream of the Met/K-Ras interaction that are important in CRC progression. As well, the biological significance of novel Met phosphorylation sites or interacting proteins will be considered. To complement this project, I am creating a parallel model system of Met/K-Ras interaction in the H460 non-small cell lung cancer (NSCLC) cell line in order to determine if any signaling mediators we find in CRC are also relevant in NSCLC. This project has a significant chance of identifying important prognostic markers, as well as targets for developing novel targeted therapies for CRC.
Competitiondate
200810
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Organ, Shawna L
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $70,000~ $0~